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Abstract
Biosynthesis of the enediyne natural product calicheamicins c1
I in Micromonospora echinospora ssp. calichensis is initiated by
the iterative polyketide synthase (PKS) CalE8. Recent studies showed that CalE8 produces highly conjugated polyenes as
potential biosynthetic intermediates and thus belongs to a family of highly-reducing (HR) type I iterative PKSs. We have
determined the NMR structure of the ACP domain (meACP) of CalE8, which represents the first structure of a HR type I
iterative PKS ACP domain. Featured by a distinct hydrophobic patch and a glutamate-residue rich acidic patch, meACP
adopts a twisted three-helix bundle structure rather than the canonical four-helix bundle structure. The so-called
‘recognition helix’ (a2) of meACP is less negatively charged than the typical type II ACPs. Although loop-2 exhibits greater
conformational mobility than other regions of the protein with a missing short helix that can be observed in most ACPs, two
bulky non-polar residues (Met
992, Phe
996) from loop-2 packed against the hydrophobic protein core seem to restrict large
movement of the loop and impede the opening of the hydrophobic pocket for sequestering the acyl chains. NMR studies of
the hydroxybutyryl- and octanoyl-meACP confirm that meACP is unable to sequester the hydrophobic chains in a well-
defined central cavity. Instead, meACP seems to interact with the octanoyl tail through a distinct hydrophobic patch without
involving large conformational change of loop-2. NMR titration study of the interaction between meACP and the cognate
thioesterase partner CalE7 further suggests that their interaction is likely through the binding of CalE7 to the meACP-
tethered polyene moiety rather than direct specific protein-protein interaction.
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Introduction
One of the most distinctive features of fatty acid, nonribosomal
peptide and polyketide biosynthetic pathways is the utilization of
the acyl carrier protein (ACP) or peptidyl carrier protein (PCP) for
the shuttling of biosynthetic intermediates among various catalytic
domains or proteins [1–5]. The small and highly dynamic ACPs or
PCPs can be either free-standing proteins or integrated domains
within a complex multidomain fatty acid synthase (FAS),
polyketide synthase (PKS) or nonribosomal peptide synthase
(NRPS). The free-standing ACPs from type II FAS pathways are
the best studied ACP systems, with crystallographic and solution
NMR studies showing that the type II FAS ACPs adopt a
canonical four-helix bundle fold with a binding pocket for
sequestering the growing fatty acid chain [6–8]. Meanwhile,
although the ACP domains from the multidomain type I FASs
adopt a similar overall structure, they do not seem to contain a
pocket for binding and protecting the growing fatty acid chain
[9–11]. Recent studies on the integrated ACP domain from the
modular type I PKS DEBS and the discrete ACPs from type II
PKS have revealed the similarity in overall protein structure but
salient differences in the binding of acyl chain between type I and
type II PKS ACPs [12–17]. Subtle differences between the ACPs
in local structure, surface electrostatic potentials and binding mode
of biosynthetic intermediates have been also documented. Recent
NMR studies further revealed functionally important protein
dynamics in PCPs for the modulation of the interaction between
the PCPs and the NRPS catalytic domains [5,18,19].
CalE8 is an iterative type I PKS that plays a central role in the
early stage of the biosynthesis of the naturally occurring enediyne
calicheamicin c1
I in Micromonospora echinospora ssp. calichensis.
Distinct from the modular type I PKSs, CalE8 is composed of a
single module consisting of several catalytic domains for the
synthesis of the putative precursor of the 10-membered enediyne
moiety [20–24]. The ACP domains of CalE8 and other enediyne
PKSs share very low sequence homology with known ACPs
[20,25,26]. In fact, the initial assignment of the ACP domain in
CalE8 was associated with a great degree of uncertainty, not just
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20549because of the low sequence homology shared with other ACPs,
but also because of the absence of the signature GX(H/D)S(L/I)
motif conserved in many ACPs. We previously confirmed the
identity of the ACP domain (meACP) in CalE8 through in vitro
modification of the excised meACP by the phosphopantetheinyl
transferase (PPTase) Sfp [27,28]. Shen and coworkers also
demonstrated that the ACP domain of SgcE, a homolog of CalE8
from the biosynthetic pathway of the 9-membered enediyne
natural product C-1027, can be phosphopantetheinylated at the
predicted Ser site by mass spectrometry [29].
According to the degree of reduction of keto groups in the final
polyketide product, iterative type I PKSs have been classified into
the non-reducing (NR), partially-reducing (PR) and highly-
reducing (HR) families (Figure 1) [21,30]. CalE8 belongs to the
HR type I PKS family given that CalE8 and its homologs produce
conjugated polyenes under both in vitro and in vivo conditions
[22,23,31,32]. To date, only one structure of the iterative type I
PKS ACP domain has been reported [33]. Crump and coworkers
determined the solution structure of the ACP domain from the
fungal norsolorinic acid synthase (NSAS), which belongs to the
iterative NR PKS family [33]. Unlike the polyketide products of
the iterative NR and PR PKSs that are cyclized immediately upon
formation, the chemically labile conjugated polyenes produced by
CalE8 seem to be stabilized by the protein to such an extent that
they can be co-purified with the protein [23,24,34]. It is thus
intriguing to speculate whether the ACP domain plays any role in
protecting the conjugated polyenes. Here we report the NMR
solution structure of the ACP domain (meACP) of CalE8, which
represents the first structure of ACP domains from an HR iterative
type I PKS. Studies on the apo, holo and acylated meACP suggest that
the modifications do not alter the overall protein structure but
affect the structure at a local level. Two-dimensional NMR spectra
of meACP collected in the presence of thioesterase (CalE7) also
provide some interesting insight into the transient nature of the
interaction between meACP and the cognate protein partner.
Results
Overall structure of meACP
The ACP domain construct used in this study encompasses a 92
residue long (Ala
925-Pro
1016) fragment of CalE8. Previous studies
have confirmed that the E. coli overexpressed meACP is in its apo
form and can be modified by the PPTase Sfp to generate holo-
meACP [27]. 98% of the residues of the recombinant apo-meACP
were unambiguously assigned. Unassigned residues are the amino-
terminal Met
924 and Ala
925. The only disordered segments are the
unstructured termini that include Ala
925 to Thr
936 and Ala
1015 to
Pro
1016 (Figure 2A). The structured region of meACP has a
backbone r.m.s. deviation of 0.44 A ˚ and no distance violation
greater than 0.5 A ˚ was observed in our structure calculation
(Table 1). Ramachandran plot of the final ten structures shows
that 98.9% of the residues fall in the allowed region (Table 1).
Overall, meACP assumes a globular fold of a twisted three-helix
bundle (a1 [Ala
938-Ala
950], a2 [Ser
971-Met
984] and a3 [Val
1001-
Figure 1. Three classes of type I iterative polyketide synthases (PKS). The proposed PKS products are tethered to the ACP domains.
doi:10.1371/journal.pone.0020549.g001
ACP Domain Structure of Type I Iterative PKS
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1014]) and two well-defined long loops (loop-1 [Glu
951-Ser
970]
and loop-2 [Met
985-Thr
1000]) (Figure 2B). The domain seems to
be stabilized through the packing of the hydrophobic side chains of
the residues originated from the three helices as well as the two
loops. The estimated helical content of 44.6% based on 41 out of
92 residues, is significantly lower than that of other known ACPs,
which usually have more than 50% of helical content [35]. Most
characterized ACPs adopts a canonical four-helix bundle structure
with helix a1 running almost anti-parallel to helices a2 and a4, as
well as a short helix a3 within the loop-2 that connects the helices
a2 and a4. In meACP, the region where the short helix should be
located seems to be disordered and the lack of the local helical
feature contributes to the low helical content of the protein. Some
ACPs and PCPs have been reported to adopt two or more inter-
converting conformations [18,36]. But we did not observe a
significant sub-population for meACP.
Local structural features
A comparison with other ACP structures reveals some salient
features of meACP. Despite the facts that meACP shares very low
sequence homology with other ACPs and it lacks the signature
GX(H/D)S(L/I) motif conserved in many ACPs (Figure 3A), the
putative phosphopantetheine attachment site (Ser
971) is still located
at the beginning of helix a2 (Figure 4). The orthodox GX(H/
D)S(L/I) motif is replaced by a H
968MSS
971I motif in meACP with
His
968 and Ser
970 substituting the canonical Gly and Asp/His
residues. The essential role of Ser
971 was confirmed by the
observation that S971A mutation completely abolished the activity
of CalE8 (data not shown). The HMS
970 triad constitutes part of
loop-1 with the solvent-exposed side chains His
968, instead of the
typical Gly residue conserved among many characterized ACPs
(Figure 4). In addition, Ser
970 replaces an Asp residue commonly
found in other type I and II ACPs. This Asp from B. subtilis FAS
ACP forms a salt bridge with the Arg
14 of ACP synthase (ACPS)
[37]. Thus, considering that such residues preceding Ser
971 have
been known to affect protein-protein interaction in some ACPs
and given the different physio-chemical property of the residues, a
dissimilar protein surface of meACP may be involved in the
recognition of some of its partners.
Figure 2. NMR structure of apo-meACP. Residues only from Ala
938-Glu
1014 are shown, excluding flexible N- and C- terminal tails. (A) Backbone of
an ensemble of the lowest energy conformations shown as line representation (B) Mean apo-meACP solution structure is shown as ribbon model.
doi:10.1371/journal.pone.0020549.g002
Table 1. Experimental restraints and structural statistics for
ten lowest-energy NMR structures of apo-meACP out of 100
structures.
NMR distance constraints
Intra-residue 628
Sequential 324
Medium-range (1,|I-j|,5) 702
Long-range (|I-j|$5) 654
Total 2308
NMR dihedral restraints
W 62
Y 63
Total 125
Structural statistics
Violations per structure (residues Gly
937-Arg
1013)
NOE violation (A ˚) 0.4160.04
Angle violation (u) 3.7460.39
TALOS .5.0u 0
Max. dihedral angle violation (u) 4.18
Max. distance constraint violation (A ˚) 0.47
Ramachandran plot region (all residues) [%]
most favoured 76.3
additionally allowed 19.4
generously allowed 3.2
disallowed 1.1
Mean RMS deviation from the average coordinates
(residues Gly
937-Arg
1013)( A ˚)
Backbone atoms (C
a, C’, N, O) 0.4460.12
All heavy atoms 1.1060.11
doi:10.1371/journal.pone.0020549.t001
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that they contain a helix a2 that is rich in acidic residues. The
clustered negative charges on helix a2 are considered to be critical
for the recognition of the free-standing ACPs by their protein
partners. Helix a2 is therefore known as the universal ‘recognition
helix’ in carrier proteins. Several acidic residues in helix a2 of type
II ACPs can form salt bridges with positively charged residues on
their protein partners [38]. However in type I FAS ACP domains
the helix a2 seems to be less negatively charged, presumably
because the specific domain-domain interaction driven by
charged-charged interactions is less critical in the multidomain
type I FAS system. In accordance with other type I ACPs, the
helix a2o fmeACP only contains a single acidic residue (Glu
980).
The resemblance of meACP to type I ACPs is also consistent with
the phylogenetic relationship of meACP with other carrier proteins
(Figure 3B). In contrast to the relatively neutral helix a2, the
adjacent loop-1 harbors a large number of highly charged residues
including Glu
951, Glu
955, Arg
958, Asp
959, Asp
960, Arg
962, Asp
965,
Asp
966 and His
968. The enrichment of the charged residues on
loop-1 is not uncommon and has also been seen in some ACPs,
such as the ones from the biosynthetic pathways of frenolicin and
norsolorinic acid [33,39]. Given the proximity of loop-1 near the
recognition helix a2, these charged residues might provide the
Figure 3. Comparison of meACP with other ACPs. (A) Multiple sequence alignment of meACP with selected type I and type II ACPs. The
secondary structures of meACP (top) and B. subtilis FAS ACP (bottom) are shown. The phosphopantetheine attaching serine site is shaded in red. (B)
Phylogenetic analysis of the type I and II ACPs from (A).
doi:10.1371/journal.pone.0020549.g003
Figure 4. Conformation of the motif harboring the phospho-
pantetheine attaching serine in meACP and two other ACPs.
The GX(H/D)S(L/I) motif in type I NSAS PKS ACP (PDB ID: 2KR5) (pink)
and type II actinorhodin PKS ACP (PDB ID: 1AF8) (orange) and the
HMSSI motif in meACP (grey) are shown as ribbons. The conserved Gly
and Ser residues in GX(H/D)S(L/I) motif are shown as stick. The His and
Ser residues of the HMSSI motif in meACP are also shown as stick.
doi:10.1371/journal.pone.0020549.g004
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phosphopantetheine arm.
It has been suggested that loop-2, which contains a short helix
for some ACPs, serves as a conformational switch in sequestering
ACP domain-tethered acyl chains in type II FAS systems [5]. With
the exceptions of act ACP and B. subtilis FAS ACP [6,16], all the
characterized ACPs contain a short helix within loop-2. The short
helix seems to be absent in meACP as well. In addition, in the case
of type II ACPs, loop-2 is largely comprised of charged or small
non-polar residues that allow the opening of a hydrophobic cleft
for binding acyl intermediates (Figure 5A); whereas loop-2 of type
I ACPs, such as NSAS ACP, usually contains bulky residues that
are packed against the protein core to prevent the opening of the
binding cleft (Figure 5B) [33]. In meACP, loop-2 also contains
two hydrophobic residues (Met
992, Phe
996) with their bulky side
chains packed against the hydrophobic core of the protein
(Figure 5C). Although the packing of Met
992 and Phe
996 may
restrict the conformational flexibility of loop-2,
1H-
15N NOE plot
of meACP indicates that the residues of loop-2 (Gly
986-Thr
1000) are
still significantly more flexible than the residues of loop-1 and
helices a1, 2 and 3 (Figure 5D). The observed conformational
flexibly of loop-2 raises the tantalizing possibility that it may
undergo a large conformational change to open a protein pocket
for binding the PKS products.
Comparison between apo- and holo-meACP
ACP domain only becomes fully functional after conversion to
holo protein with a phosphopantetheine group attached to the
invariant Ser residue. To find out whether the presence of the
phosphopantetheine group perturbs the meACP structure and
Figure 5. Conformation mobility of loop-2. (A) Type II actinorhodin PKS ACP (PDB ID: 1AF8) that contain mainly small residues in loop-2. (B)
Type I NSAS PKS ACP (PDB ID: 2KR5) with the two bulky residues (Phe
1768 and Phe
1771) highlighted (C) meACP with the two bulky residues (Phe
996
and Met
992) packed against the hydrophobic pocket highlighted. (D).
1H-
15N NOE plot of apo-meACP acquired at an 800 MHz spectrometer at 25uC.
The positions of the helices are indicated.
doi:10.1371/journal.pone.0020549.g005
ACP Domain Structure of Type I Iterative PKS
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e20549dynamics, the holo form of the protein was prepared by
incubating meACP with coenzyme A and the PPTase Sfp.
Comparing the HSQC spectra of apo-a n dholo-meACP, we found
that the overall structures of the two forms are essentially the
same (Figure 6). Nonetheless, Ser
971 exhibits a large shift from
the apo form (
1H: 8.97 ppm,
15N: 116.80 ppm) to the holo form
(
1H: 9.28 ppm,
15N: 116.50 ppm) or a combined chemical shift
change of 0.31 ppm. The presence of the phosphopantetheine
group also clearly affects backbone amides of the neighbor-
ing residues that include Asp
965 and Ser
970 from loop-1, Ile
972,
Gly
975 and Val
978 from helix a2a n dT h r
994,T h r
998,A l a
999 and
Thr
1000 from loop-2 (Figure 7A and 7G). These perturbed
residues are mostly located at protein surface in the vicinity of
Ser
971 (with the exception of Val
978 that is probably due to a
subtle conformational change in helix a2). The observation
indicates that the meACP-attached phosphopantetheinyl group is
most likely to be exposed to solvent and accessible to other
catalytic domains.
Interaction of acylated moiety with meACP
One of the most interesting findings about PKS/FAS and
NRPS is the presence of a ligand binding pocket on the surface of
type II ACPs or PCPs for the binding of the growing
intermediates. For example, the sequestering of aliphatic segment
of decanoate (10:0) or stearate (18:0) in the binding pocket of
spinach ACP induces striking perturbations of HSQC peaks
[40,41]. On the other hand, hexanoyl (6:0) or palmitoyl (16:0)
chain attached to type I rat FAS ACP showed little changes of
HSQC peaks, suggesting that the rat FAS ACP does not bind the
aliphatic chain [9].
Given the observed conformational flexibility of loop-2 in
meACP, we asked whether type I meACP can also bind the
chemically labile polyene intermediates in the same hydrophobic
pocket that accommodates the side chains of Met
992 and Phe
996.
Loading meACP with the highly conjugated polyenes is impractical
given the chemical reactivity of the polyenes. Instead, we used
hydroxybutyryl- and octanoyl- groups to mimic the aliphatic
chains of the polyene products. Overall, only minor perturbations
in
1H-
15N HSQC spectrum were observed between the holo- and
acylated-meACPs, suggesting that residues lining the putative
binding pocket are not disturbed (Figure 6). However, although
only negligible differences between the holo- and hydroxybutyryl-
meACP (combined chemical shift differences ,0.05 ppm) were
observed, extending the acyl chain from hydroxybutyryl to
octanoyl causes greater and more extensive chemical shift changes
(0.05–0.20 ppm) (Figure 7B-F). With a chemical shift change
cutoff of 0.05 ppm, eight residues that include Ser
971, Gly
975,
Asn
979, Arg
983, Ala
991, Thr
1000, Ala
1007 and Arg
1011 exhibit
greater perturbation in octanoyl-meACP than hydroxybutyryl-meACP.
Note that the three residues Ser
971, Gly
975 and Thr
1000 are
affected by both phosphopantetheinylation and extension of the
acyl chain, indicating that elongation of acyl chain may also alter
the position or conformation of the phosphopantetheinyl moiety.
These perturbed residues of octanoyl-meACP are mapped on the
protein and most of them are located on helix a2, loop-2 and as
well as helix a3( Figure 7H).
Figure 6. Overlaid
1H-
15N HSQC spectra of apo-meACP and its derivatives. apo-meACP (black), holo-meACP (A, yellow), hydroxybutyryl-
meACP (B, green) and octanoyl-meACP (C, red) acquired at 15uC. The change of chemical shifts for the residues Ser
971 and Gly
975 from apo, holo,
hydroxybutyryl to octanoyl-meACP are indicated by the black arrows.
doi:10.1371/journal.pone.0020549.g006
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PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e20549Figure 7. Chemical shift perturbations (Dd)o fmeACP caused by phosphopantetheinylation and acylation. Combined chemical shift
change plots of apo-meACP versus (A) holo-meACP, (B) hydroxybutyryl-meACP and (C) octanoyl-meACP. Combined chemical shift change plots of (D)
hydroxybutyryl-meACP versus holo-meACP, (E) octanoyl-meACP versus holo-meACP and (F) octanoyl-meACP versus hydroxybutyryl-meACP. A combined
chemical shift cut-off of 0.05 ppm is shown as the dashed line. The residue number and the positions of the helices (a1, a2 and a3) are also indicated.
(G) Ribbon representation of apo-meACP with the positions of the perturbed residues upon phosphopantetheinylation are highlighed (combined
chemical shift cut-off .0.05 ppm (yellow sphere) and .0.10 ppm (red sphere)). (H) Ribbon representation of apo-meACP with the positions of the
perturbed residues based on (F) upon acylation by octanoyl moiety are highlighted (combined chemical shift cut-off .0.05 ppm (blue sphere)).
doi:10.1371/journal.pone.0020549.g007
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meACP domain must interact with the ketosynthase (KS),
acyltransferase (AT), Ketoreductase (KR), dehydratase (DH) and
PPTase domains of CalE8 for the synthesis of the polyene product
as well as the thioesterase CalE7 for hydrolytic release of the
product. It would be interesting to know the molecular basis of the
interaction between meACP and the catalytic domain of CalE8 as
well as CalE7. However, cloning and expression of the stand-alone
catalytic domains of CalE8 failed to produce soluble proteins. We
were only able to examine the interaction between meACP and the
hot-dog fold thioesterase CalE7 in an attempt to map out the
recognition surface of meACP for CalE7. When we first
determined the crystal structure of CalE7, a few charged residues
at the entrance of the substrate-binding tunnel were speculated to
be involved in binding meACP [34]. However, when the
thioesterase CalE7 was titrated into the
15N-labeled apo- and
holo-meACP protein solution for NMR measurement, no HSQC
peak was perturbed in both chemical shifts and intensity even
when the ratio of CalE7 to meACP reached 2.5:1. This indicates
that the interaction between CalE7 and meACP is too transient or
weak to be detected (Figure S1 and S2). The transient nature of
the CalE7 and meACP interaction is further supported by the
observation that none of the charged residues at the substrate-
binding channel is conserved in the homologous DynE7 protein
[42]. In conjunction with the observation that a catalytic
incompetent mutant of CalE7 (but not the wild type CalE7) can
form stable 1:1 complex with CalE8 with the conjugated polyene
products remaining attached to the ACP domain [42], it is
reasonable to believe that the interaction between meACP and
CalE7 is rather weak and the recognition is through the binding of
the nascent polyene product in the hydrophobic substrate channel
of CalE7. The weak transient interaction will be further explored
using paramagnetic relaxation enhancement approaches.
Discussion
As the first structure determined for the ACP domain of a
highly-reducing (HR) iterative type I PKS, meACP shares
extremely low sequence homology with other known ACPs,
including the ACP domain of the non-reducing (NR) iterative type
I PKS NSAS (12% identity). meACP also features an unusual
HMSSI motif (or H(L/M)(S/T/N)S(I/L) for meACP homologs)
harboring the putative Ser
971 phosphopantetheinylation site, in
contrast to the more common GX(H/D)S(L/I) motif seen in other
ACPs. We have previously performed site-directed mutagenesis to
show that Ser
971, but not Ser
970, is required for the enzymatic
function of CalE8 (data not shown). The specificity towards Ser
971
must be determined by the location of the residue and its
proximity to the CoA substrate in the meACP-PPTase complex. As
there is a ,7.0 A ˚ distance between the two hydroxyl groups for
the two Serine residues, it is unlikely for the PPTase domain to
modify the wrong Serine (Ser
970).
Despite the low sequence homology and the uncommon
HMSSI motif, meACP adopts a helix-bundle structure that is
highly similar to other ACPs with the exception of the absence of
the short helix within loop-2. As a result of the missing short helix,
the structure of meACP is best described as a twisted three-helix
bundle instead of the canonical four helix-bundle structure. In
addition, the relatively shortage of negative charges on the
‘recognition helix’ (a2) of meACP is consistent with the observa-
tions for other type I FAS and PKS ACPs, presumably resulted
from the lack of evolutionary selection pressure on type I ACP
domains for specific domain-domain interactions within the
multidomain FAS or PKS protein.
It is well known that loop-2 of type II FAS and PKS ACPs
generally consists of charged and less bulky residues to confer great
conformational mobility to the loop; whereas type I ACPs tend to
contain bulky hydrophobic residues on the loop to restrict the
mobility of the loop through hydrophobic interaction with the
protein core. In light of this, meACP harbors two non-polar
residues (Met
992 and Phe
996) with the side chains packed against
the protein core. Similar hydrophobic interactions were recently
reported for the ACP domains of the rat type I FAS, the non-
reducing (NR) types I iterative PKS NSAS and the type I modular
PKS DEBS [9,33]. The protection of the intermediates is
considered to be particularly important for type II FASs and
PKSs because the free-standing ACPs need to transport the
intermediates from one protein to another in the cytoplasm. The
conformational mobility of loop-2 has been suggested to be crucial
for the opening of a hydrophobic cleft for sequestering and
protecting acyl intermediates. Such protection, however, is less
critical for type I FASs and PKSs with the integrated ACP domain
and intermediates probably already shielded from solvent by the
surrounding catalytic domains. The structural observations thus
seem to reinforce the view that restricted conformational mobility
of loop-2 resulted from interaction of the non-polar residues may
be a common feature for the ACP domains of the multidomain
type I FAS and type I iterative PKS.
Despite the hydrophobic interaction between Met
992 and
Phe
996 with the protein core, the
1H-
15N NOE plot revealed
relatively greater conformational flexibility for loop-2 than loop-1
and the three helices (Figure 5D). This observation first raised the
question whether loop-2 of meACP still can undergo conformation
change to create a transient protein pocket for binding the highly
hydrophobic polyene products. Attachment of 49-phosphospan-
teine group and the additional hydroxybutyryl group to the Ser
971
site has little effect on the overall protein fold, despite minor local
perturbations restricted to residues in the vicinity of Ser
971
(Figure 7). These observations suggest that the phosphopan-
tetheine and hydroxybutyryl moieties are unlikely to be bound in a
protein pocket and thus remain in the bulk solvent. In contrast, the
NMR spectra of the octanoyl-meACP show more extensive
perturbations, with the perturbed residues distributed in a region
flanked by helix a2, loop-2 and helix a3( Figure 7H). The
magnitude of the perturbation is considered to be relatively small
compared to that for the type II ACPs that sequester the acyl chain
through a significant conformational change [13,43], Hence, the
results do not seem to support that meACP is able to undergo
dramatic conformational change and sequester the PKS product
in a well-defined protein pocket. Instead, examination of the
electrostatic potential surface of meACP reveals two distinct
patches, a unique hydrophobic patch and an acidic patch unlike
other ACPs currently deposited in Protein Data Bank (PDB)
(Figure 8). The rather common charged patch encompassing the
recognition helix a2 observed in other ACPs, is replaced by an
unusual hydrophobic patch in meACP (Figure 8E). meACP also
features an acidic patch that consists mainly Glu residues,
including Glu
940 and Glu
948 from helix a1, Glu
951 and Glu
955
from loop-1, Glu
980 from helix a2, and Glu
1003, Glu
1006, Glu
1009,
Glu
1012 and Glu
1014 from helix a3. (Figure 8I and Figure 9). No
such hydrophobic or acidic patch has been observed in other type
I ACPs, such as the rat FAS ACP and NSAS PKS ACP or type II
ACPs such as actinorhodin PKS ACP (Figure 8) [33]. Given the
location of the hydrophilic patch and the observed NMR
perturbations with the eight residues in the distinct hydrophobic
surface of meACP, it is feasible that the non-polar octanoyl chain
may interact with hydrophobic patch to avoid the unfavorable
solvation of the hydrophobic groups. Such hydrophobic interac-
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PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e20549Figure 8. Embedded ribbon representation and electrostatic potential surface of ACPs. Type I meACP (A, E and I), rat FAS ACP (B, F and J,
PDB ID: 2PNG), NSAS PKS ACP (C, G and K, PDB ID: 2KR5) and Type II actinorhodin PKS ACP (D, H and L, PDB ID: 1AF8). The invariant Ser is shown as
blue stick and labeled. The protein surfaces are colored as white (hydrophobic), blue (basic) and red (acidic) with the same electrostatic potential
scale.
doi:10.1371/journal.pone.0020549.g008
Figure 9. Ribbon representation of apo-meACP with either hydrophobic or acidic face. The hydrophobic and Glu-Asp acidic faces are
shown with highlighted spheres colored red (Glu) and orange (Asp).
doi:10.1371/journal.pone.0020549.g009
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polyene intermediates during chain elongation. Alternatively, the
hydrophobic patch could be conserved for domain-domain
interaction. The latter remains a possibility considering that this
region also encompasses the helix a2 that is most likely to be
involved in protein-protein interaction.
The biosynthetic mechanisms for the 10- and 9-membered
enediyne moieties and the precise function of CalE8 and its
homologs are currently under intensive investigation. The first
structure of the HR iterative PKS ACP domain presented here not
only reveals some interesting structure features that reinforce some
of the views held for type I FAS and PKS ACPs, but also discloses
some unique characteristics of the meACP domain. The lack of a
strong negatively charged helix a2 and the moderate conforma-
tional flexibility of loop-2 are consistent with the role of the meACP
domain in shuttling acyl intermediates within the catalytic
chamber of the multidomain PKS CalE8. The absence of the
short helix within loop-2 is rare but not totally unprecedented. The
interaction between the acyl aliphatic chain and the hydrophobic
patch is distinct from the well-established interaction between acyl
chains and the well-defined protein pocket. Although the
biological significance of the hydrophobic patch and highly acidic
patch remain to be established, the hydrophobic patch may be
involved in the interaction with other catalytic domain, or play a
role by interacting and stabilizing the intermediates and products
of CalE8. Lastly, the lack of significant binding between meACP
and its cognate protein partner CalE7 indicates that specific strong
protein-protein recognition is not crucial for CalE7 to bind and
perform the hydrolytic cleavage on the product of CalE8.
Materials and Methods
Protein cloning, expression and purification
The cloning of meACP domain has also been described
previously [27]. The ACP and catalytic domains of CalE8 were
cloned into compatible vectors and transformed into BL21 cells for
expression. Seed culture of BL21 cells containing the respective
plasmids were grown overnight before being inoculated into large
scale cultures. The cultures were allowed to grow at 37uC and
200 rpm until the OD600nm reached 0.6. Induction was done with
IPTG at 0.4 mM concentration. Cells were harvested 20 hours
later after being left to grow at 16uC and 160 rpm. The cell pellet
was then resuspended in lysis buffer (50 mM HEPES at pH 7.5,
300 mM NaCl, 5% glycerol, 5 mM b-mercaptoethanol). Subse-
quently the cells were lysed by sonication. The supernatant
obtained after high speed centrifugation was applied onto Ni
2+-
NTA column for purification with a stepped gradient. The final
eluent containing the recombinant protein was applied onto gel-
filtration column Superdex75 or Superdex200 depending on the
size of the individual protein for further purification in a buffer
suitable for NMR experiments (50 mM NaH2PO4/Na2HPO4 at
pH 6.85, 50 mM NaCl, 1 mM DTT). The fractions containing
the protein were pooled and concentrated. After that, the proteins
solutions were stowed away in the 280uC freezer for future NMR
analysis. The same expression and purification protocols were used
to prepare
15N,
13C-labeled meACP protein by using an M9
medium containing
15N-isotopic ammonium chloride and
13C
isotopic glucose. The labeled protein obtained from gel filtration
was further purified with a Mono Q column. A refined gradient
was employed using buffer A (50 mM NaH2PO4/Na2HPO4,
1 mM DTT) and buffer B (50 mM NaH2PO4/Na2HPO4,1M
NaCl, 1 mM DTT). The salt gradient increased gradually from
0% to 40% of B in 50 ml. The majority of the meACP did not bind
to the column and was eluted at early stage of the gradient. The
fractions containing meACP were pooled and concentrated for
NMR as well as acylation experiments. The thioesterase CalE7
were cloned, expressed and purified as described [23,34]. The
PPTase Sfp used for modification of meACP was prepared
according to the established procedure [27].
Preparation of holo- and acylated-meACP
The reaction for the production of holo- and hydroxybutyryl-
meACPs were summarized as follows: 400 ml of ACP (12 mg/ml),
100 ml of Sfp (68 mg/ml), 40 ml of CoA or acyl-CoA (50 mM) and
10 ml of MgCl2 (1 M) were mixed together in 1 ml of reaction
buffer (100 mM Tris at pH 8.2, 300 mM NaCl, 1 mM DTT).
The reaction was carried out at 30uC for 8–12 hours. The
progress of the conversion was monitored by HPLC analysis using
an eclipse XDB RP C8 column at 2 hour intervals. The gradient
employed was from 10% of acetonitrile to 90% acetonitrile in half
an hour. Elution of meACP and Sfp were monitored at the
wavelength of 220 nm. Upon completion of the reaction, the
mixture was desalted with NaH2PO4/Na2HPO4 buffer without
NaCl to bring down the NaCl concentration to ,50 mM.
Aforementioned refined gradient was employed using MonoQ
for the separation of holo- or acylated-meACP from Sfp. A gel
filtration step with Superdex-75 column was added to further
improve the purity of the holo- and hydroxybutyryl-meACP. For the
production of octanoyl-meACP, the reaction buffer was modified to
have the following composition: 50 mM NaH2PO4/Na2HPO4 at
pH 7.0, 200 mM NaCl, and 1 mM DTT. The duration of the
reaction was prolonged to 16 to 20 hours at 25uC and the
conversion rate for the modifications is .95%.
NMR spectroscopy
All NMR experiments were performed on an 800 MHz NMR
spectrometer (Bruker) unless otherwise indicated. All NMR
samples including ACPs and CalE7 were prepared in a buffer
with 50 mM NaH2PO4/Na2HPO4 at pH 6.85, 50 mM NaCl,
1 mM EDTA, 1 mM DTT, 5% D2O. Because the meACP protein
has weak UV absorbance at 280 nm due to the lack of Trp
residues, the protein concentrations were determined by the
Bradford assay at 595 nm. To determine the structure of apo-
meACP, we collected the following NMR spectra on a ,1m M
13C,
15N-labeled protein sample: 2D
1H-
15N HSQC, 2D
1H-
13C
HSQC, 3D HN(CO)CA, 3D HNCA, 3D MQ-(H)CCH-
TOCSY[44] and 4D timeshared
13C/
15N edited-NOESY [45].
To measure the heteronuclear NOEs, two spectra without and
with proton saturation were measured on a ,1m M
15N-labeled
sample with a saturation delay of 4 s and recycle delay of 4 s by
the inverse-detected 2D NMR method. Proton saturation was
achieved by a train of 120u pulses spaced at 5 ms.
In the thioesterase CalE7 titration experiments, an initial
concentrated unlabeled CalE7 protein solution (0.8 mM) was
added to
15N-labeled apo-meACP (0.3 mM) or
15N-labeled holo-
meACP (0.3 mM). The samples were first allowed to incubate for
10 min prior to NMR data collection. TROSY-HSQCs were
recorded at three CalE7 concentrations (0 mM, 0.22 mM and
0.38 mM) in the same ACP buffer till a final [meACP] of 0.15 mM
or molar ratio [CalE7]: [meACP] of 2.5:1. All data were processed
with NMRpipe and analyzed with NMRspy and an extension
XYZ4D (http://yangdw.science.nus.edu.sg/Software&Scripts/
XYZ4D/index.htm). NMRspy was recently developed to facilitate
resonance assignment with the 4D NOESY-based strategy [46].
1H-
15N HSQCs of apo-, holo-, hydroxybutyryl- and octanoyl-meACP
(0.1 mM) were acquired at 15uC instead of 25uC on an 800 MHz
NMR spectrometer. This allows us to observe Ser
971 which was
predominantly weak at higher temperature .20uC using 0.1 mM
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calculated using equation 1:
Dppm ~ DdHN ðÞ
2 z DdN=7 ðÞ
2
hi 0:5
ð1Þ
where DdHN and DdN are the respective differences of
1H and
15N
chemical shifts between different forms of meACP: apo-meACP,
holo-meACP or acylated-meACP (hydroxybutyryl- and octanoyl-meACP).
Structure calculation
NOE restraints were obtained from the timeshared 4D
13C/
15N-edited NOESY (containing
13C,
15N-edited,
13C,
13C-
edited and
15N,
15N-edited subspectra) using NMRspy. -Backbone
torsional angle restraints, W and Y were obtained from chemical
shift data using TALOS [47]. Ambiguous NOEs were assigned
with the iterative structure calculation method using Cyana 2.1
[48]. The final 10 lowest energy structures out of 100 calculated
were selected. The quality of the structure was assessed using
PROCHECK [49].
The NMR assignment data is deposited in the BioMagResBank
under BMRB accession number 17355. The coordinates of the
ensemble of 10 structures have been deposited in the Protein Data
Bank (PDB ID: 2L9F).
Supporting Information
Figure S1
1H-
15N HSQC of
15N-labeled apo-meACP
titrated against unlabeled CalE7. The titration is performed
at 25uC in monomeric apo-meACP: CalE7 molar ratio of (A) 1:0
(black) (B) 1:1 (blue) (C) 1:2.5 (red) and (D) an overlaid spectrum
between (A) and (C).
(TIF)
Figure S2
1H-
15N HSQC of
15N-labeled holo-meACP
titrated against unlabeled CalE7. The titration is performed
at 25uC till monomeric holo-meACP: CalE7 molar ratio of (A) 1:0
(black) (B) 1:1 (blue) (C) 1:2.5 (red) and (D) an overlaid spectrum
between (A) and (C).
(TIF)
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